YDC Data Monetization Index for Life Sciences

December 17, 2021 Summary The YDC Data Monetization Index (DMI) for Life Sciences varies by industry and company: Pharmaceutical companies like Merck and Johnson & Johnson have YDC DMIs in the 6%-7% range Smith & Nephew has a DMI of 30.1%, the only pure-play medical device company in our analysis although we did also factor […]

Webinar: Data Monetization for Life Sciences

Join us for a webinar on June 17 where we will share an overview of Data Monetization in the Life Sciences Industry.   Industry experts will discuss how YDC supports data monetization through a data balance sheet covering all data assets and data liabilities related to Life Sciences data cycle. You will learn more about how the YDC Platform […]

Valuation of Life Sciences Clinical Trial Data and Data Balance Sheet Using YDC

Sunil Soares CEO, YourDataConnect Clinical trials generate data that has an uncertain value. A trial may or may not be successful, and it may generate revenues that are uncertain. We leveraged YDC to develop a valuation model for Phase III clinical trials for an oncology (cancer) drug. As a first step, we created a Clinical […]